Large scale COVID-19 studies and clinical trials should collect data on menstrual changes, according to new research which evaluated current evidence. The findings, published in the International Journal of Epidemiology and led by University of Bristol researchers, say there is an important public health imperative for accurate scientific investigation of menstrual changes in relation to the COVID-19 pandemic.
The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought, suggest two new studies which included work led by University of Bristol researchers. The findings and a linked editorial are published today [4 November] in Thorax .
Aspirin can reduce the risk of serious cardiovascular events such as ischemic stroke and heart attack in patients with pneumonia, according to new research.
American-British actress, comedian, writer, mental health campaigner and lecturer - Ruby Wax - will headline the Good Grief Festival, which returns later this month (Saturday 30 and Sunday 31 October).
Many people experience peace of mind from getting their children vaccinated, according to new research from the University of Bristol. However, this benefit is currently being ignored when health bodies weigh up vaccine benefits to make decisions about whether or not to introduce vaccines or expand their coverage.
One of the largest studies to investigate whether Preserved Ratio Impaired Spirometry (PRISm), an understudied low lung function state, is an early predictor of co-morbidities has found it is strongly associated with an increased risk of death. The analysis, led by University of Bristol researchers and published in The Lancet Respiratory Medicine, evaluated results of lung spirometry tests in over 350,000 UK adults and followed them up over 12 years.
Bristol is to benefit from a £4 million funding boost from the National Institute for Health Research (NIHR) to fund a new Health Protection Research Unit in Behavioural Science and Evaluation.
A truly ground-breaking approach to cardiovascular health involving wearable technology and sensors in the home, expanding on pioneering University of Bristol research, has been shortlisted for the British Heart Foundation (BHF) Big Beat Challenge £30 million award.
Balancing improvements in health against the cost of such improvements in primary care is vital to achieve a cost-effective and efficient healthcare system, finds a new report by University of Bristol researchers and published in the BMJ.
Researchers from the University of Bristol and University Hospital Southampton have found that a drug used widely to treat a common eye condition has “no benefit” and should no longer be used. Eplerenone, which is primarily used to treat heart failure, is currently offered widely by ophthalmologists as a treatment for central serous chorioretinopathy (CSCR) based on limited clinical data.
